- Home
- BWFG vs IMMP Comparison
BWFG vs IMMP Comparison
Compare BWFG & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWFG
- IMMP
- Stock Information
- Founded
- BWFG 2002
- IMMP 1987
- Country
- BWFG United States
- IMMP Australia
- Employees
- BWFG N/A
- IMMP N/A
- Industry
- BWFG Major Banks
- IMMP Biotechnology: Pharmaceutical Preparations
- Sector
- BWFG Finance
- IMMP Health Care
- Exchange
- BWFG Nasdaq
- IMMP Nasdaq
- Market Cap
- BWFG 230.4M
- IMMP 211.1M
- IPO Year
- BWFG N/A
- IMMP N/A
- Fundamental
- Price
- BWFG $34.60
- IMMP $1.86
- Analyst Decision
- BWFG Buy
- IMMP Buy
- Analyst Count
- BWFG 1
- IMMP 2
- Target Price
- BWFG $42.00
- IMMP $8.50
- AVG Volume (30 Days)
- BWFG 13.1K
- IMMP 648.0K
- Earning Date
- BWFG 04-23-2025
- IMMP 05-16-2025
- Dividend Yield
- BWFG 2.35%
- IMMP N/A
- EPS Growth
- BWFG N/A
- IMMP N/A
- EPS
- BWFG 1.62
- IMMP N/A
- Revenue
- BWFG $69,109,000.00
- IMMP $3,019,249.00
- Revenue This Year
- BWFG $58.05
- IMMP $11.25
- Revenue Next Year
- BWFG $12.43
- IMMP $10.22
- P/E Ratio
- BWFG $20.97
- IMMP N/A
- Revenue Growth
- BWFG N/A
- IMMP 24.11
- 52 Week Low
- BWFG $22.80
- IMMP $1.32
- 52 Week High
- BWFG $35.25
- IMMP $3.34
- Technical
- Relative Strength Index (RSI)
- BWFG 68.45
- IMMP 53.43
- Support Level
- BWFG $33.20
- IMMP $1.44
- Resistance Level
- BWFG $34.94
- IMMP $2.71
- Average True Range (ATR)
- BWFG 0.82
- IMMP 0.17
- MACD
- BWFG 0.30
- IMMP 0.05
- Stochastic Oscillator
- BWFG 94.97
- IMMP 29.75
About BWFG Bankwell Financial Group Inc.
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.